Skip to main content
Erschienen in: European Surgery 5/2016

01.10.2016 | letter to the editor

Esophagectomy for eosinophilic esophagitis: how to avoid it

verfasst von: Alfredo J Lucendo, MD, PhD, FEBGH

Erschienen in: European Surgery | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Summary

Patients with eosinophilic esophagitis (EoE) can currently benefit from an evidence-based medical and dietary treatment according to knowledge accumulated from observational studies and randomized controlled trials, the results of which were summarized in several systematic reviews and meta-analyses. Surgery is relegated to solving some uncommon complications of EoE and has been exclusively applied in a handful of cases of esophageal perforation. This letter to the editor criticizes the only case of elective esophagectomy carried out in a 27-year-old male with EoE and longstanding dysphagia, which was unresponsive to obstinate endoscopy-based treatment. Despite medical and dietary treatment, strategies in EoE must still be improved and basing the clinical management of sufferers on the application of therapies with demonstrated effectiveness instead of empirical strategies is highly desirable.
Literatur
1.
Zurück zum Zitat Molina-Infante J, et al. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut. 2016;65(3):524–31.CrossRefPubMed Molina-Infante J, et al. Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut. 2016;65(3):524–31.CrossRefPubMed
2.
Zurück zum Zitat Arias A, et al. Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2016;43(1):3–15.CrossRefPubMed Arias A, et al. Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2016;43(1):3–15.CrossRefPubMed
3.
Zurück zum Zitat Gonzalez-Cervera J, Lucendo AJ. Eosinophilic Esophagitis: an evidence-based approach to therapy. J Investig Allergol Clin Immunol. 2016;26(1):8–18.CrossRefPubMed Gonzalez-Cervera J, Lucendo AJ. Eosinophilic Esophagitis: an evidence-based approach to therapy. J Investig Allergol Clin Immunol. 2016;26(1):8–18.CrossRefPubMed
4.
Zurück zum Zitat Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal Eosinophilia: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(1):13–22.CrossRefPubMed Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal Eosinophilia: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(1):13–22.CrossRefPubMed
5.
Zurück zum Zitat Molina-Infante J, et al. Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis. Am J Gastroenterol. 2015;110(11):1567–75.CrossRefPubMed Molina-Infante J, et al. Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis. Am J Gastroenterol. 2015;110(11):1567–75.CrossRefPubMed
6.
Zurück zum Zitat Lucendo AJ, et al. Empiric 6‑food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131(3):797–804.CrossRefPubMed Lucendo AJ, et al. Empiric 6‑food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131(3):797–804.CrossRefPubMed
7.
Zurück zum Zitat Molina-Infante J, et al. Four-food group elimination diet for adult eosinophilic esophagitis: A prospective multicenter study. J Allergy Clin Immunol. 2014;134(5):1093–9.CrossRefPubMed Molina-Infante J, et al. Four-food group elimination diet for adult eosinophilic esophagitis: A prospective multicenter study. J Allergy Clin Immunol. 2014;134(5):1093–9.CrossRefPubMed
8.
Zurück zum Zitat Dellon ES, et al. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology. 2012;143(2):321–4.CrossRefPubMedPubMedCentral Dellon ES, et al. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology. 2012;143(2):321–4.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Miehlke S, et al. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut. 2016;65(3):390–9.CrossRefPubMed Miehlke S, et al. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut. 2016;65(3):390–9.CrossRefPubMed
10.
Zurück zum Zitat Lieberman JA, et al. Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort. Allergy. 2012;67(10):1299–307.CrossRefPubMed Lieberman JA, et al. Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort. Allergy. 2012;67(10):1299–307.CrossRefPubMed
11.
Zurück zum Zitat Aceves SS, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65(1):109–16.CrossRefPubMed Aceves SS, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65(1):109–16.CrossRefPubMed
12.
Zurück zum Zitat Fontillon M, Lucendo AJ. Transmural eosinophilic infiltration and fibrosis in a patient with non-traumatic Boerhaave’s syndrome due to eosinophilic esophagitis. Am J Gastroenterol. 2012;107(11):1762.CrossRefPubMed Fontillon M, Lucendo AJ. Transmural eosinophilic infiltration and fibrosis in a patient with non-traumatic Boerhaave’s syndrome due to eosinophilic esophagitis. Am J Gastroenterol. 2012;107(11):1762.CrossRefPubMed
13.
Zurück zum Zitat Lucendo AJ, Friginal-Ruiz AB, Rodriguez B. Boerhaave’s syndrome as the primary manifestation of adult eosinophilic esophagitis. Two case reports and a review of the literature. Dis Esophagus. 2011;24(2):E11–E15.CrossRefPubMed Lucendo AJ, Friginal-Ruiz AB, Rodriguez B. Boerhaave’s syndrome as the primary manifestation of adult eosinophilic esophagitis. Two case reports and a review of the literature. Dis Esophagus. 2011;24(2):E11–E15.CrossRefPubMed
Metadaten
Titel
Esophagectomy for eosinophilic esophagitis: how to avoid it
verfasst von
Alfredo J Lucendo, MD, PhD, FEBGH
Publikationsdatum
01.10.2016
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 5/2016
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-016-0441-1

Weitere Artikel der Ausgabe 5/2016

European Surgery 5/2016 Zur Ausgabe